{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:09:43Z","timestamp":1792404583471,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00259-024-06727-5","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T03:09:57Z","timestamp":1714360197000},"page":"1809-1815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Nuclear medicine practice for the assessment of cardiac sarcoidosis and amyloidosis. A survey endorsed by the EANM and EACVI."],"prefix":"10.1007","volume":"51","author":[{"given":"Irene","family":"Gotuzzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riemer H.J.A.","family":"Slart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Gimelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Ashri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bucerius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny R.","family":"Buechel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Gaemperli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gheysens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andor W.J.M.","family":"Glaudemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Hyafil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lubberink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Saraste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomaz","family":"Podlesnikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Dweck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola A.","family":"Erba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"issue":"10","key":"6727_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3238\/arztebl.2020.0159","volume":"117","author":"S Ihne","year":"2020","unstructured":"Ihne S, Morbach C, Sommer C, Geier A, Knop S, St\u00f6rk S. Amyloidosis-the diagnosis and treatment of an underdiagnosed disease. Dtsch Arztebl Int. 2020;117(10):159\u201366. https:\/\/doi.org\/10.3238\/arztebl.2020.0159","journal-title":"Dtsch Arztebl Int"},{"key":"6727_CR2","doi-asserted-by":"publisher","unstructured":"Arcana RI, Cri\u0219an-Dabija R, Cernomaz AT, et al. The risk of sarcoidosis misdiagnosis and the harmful effect of corticosteroids when the disease picture is incomplete. Biomedicines. 2023;11(1). https:\/\/doi.org\/10.3390\/biomedicines11010175","DOI":"10.3390\/biomedicines11010175"},{"issue":"3","key":"6727_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jccase.2015.05.015","volume":"12","author":"U Ikeda","year":"2015","unstructured":"Ikeda U, Editorial. Diagnosis of cardiac sarcoidosis - what is the role of endomyocardial biopsy? J Cardiol Cases. 2015;12(3):72\u20133. https:\/\/doi.org\/10.1016\/j.jccase.2015.05.015","journal-title":"J Cardiol Cases"},{"issue":"9","key":"6727_CR4","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jchf.2020.04.007","volume":"8","author":"VS Hahn","year":"2020","unstructured":"Hahn VS, Yanek LR, Vaishnav J, et al. Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis. JACC Heart Fail. 2020;8(9):712\u201324. https:\/\/doi.org\/10.1016\/j.jchf.2020.04.007","journal-title":"JACC Heart Fail"},{"issue":"6","key":"6727_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.carpath.2015.07.008","volume":"24","author":"JJ Maleszewski","year":"2015","unstructured":"Maleszewski JJ. Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovasc Pathol. 2015;24(6):343\u201350. https:\/\/doi.org\/10.1016\/j.carpath.2015.07.008","journal-title":"Cardiovasc Pathol"},{"issue":"24","key":"6727_CR6","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133(24):2404\u201312. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.021612","journal-title":"Circulation"},{"issue":"6","key":"6727_CR7","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.jcmg.2019.07.015","volume":"13","author":"S Dorbala","year":"2020","unstructured":"Dorbala S, Cuddy S, Falk RH. How to image cardiac amyloidosis: a practical approach. JACC Cardiovasc Imaging. 2020;13(6):1368\u201383. https:\/\/doi.org\/10.1016\/j.jcmg.2019.07.015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"6727_CR8","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00259-018-4013-4","volume":"45","author":"G Treglia","year":"2018","unstructured":"Treglia G, Glaudemans AWJM, Bertagna F, et al. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis. Eur J Nucl Med Mol Imaging. 2018;45(11):1945\u201355. https:\/\/doi.org\/10.1007\/s00259-018-4013-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"6727_CR9","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","volume":"18","author":"DF Hutt","year":"2017","unstructured":"Hutt DF, Fontana M, Burniston M, et al. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid. Eur Heart J Cardiovasc Imaging. 2017;18(12):1344\u201350. https:\/\/doi.org\/10.1093\/ehjci\/jew325","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"6727_CR10","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","volume":"1","author":"A Castano","year":"2016","unstructured":"Castano A, Haq M, Narotsky DL, et al. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol. 2016;1(8):880\u20139. https:\/\/doi.org\/10.1001\/jamacardio.2016.2839","journal-title":"JAMA Cardiol"},{"issue":"1","key":"6727_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00259-023-06381-3","volume":"51","author":"HSA Tingen","year":"2023","unstructured":"Tingen HSA, Tubben A, van \u2019t Oever JH, et al. Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: a systematic review. Eur J Nucl Med Mol Imaging. 2023;51(1):93\u2013109. https:\/\/doi.org\/10.1007\/s00259-023-06381-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"6727_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12350-017-1059-9","volume":"26","author":"RHJA Slart","year":"2019","unstructured":"Slart RHJA, Glaudemans AWJM, Hazenberg BPC, Noordzij W. Imaging cardiac innervation in amyloidosis. J Nucl Cardiol. 2019;26(1):174\u201387. https:\/\/doi.org\/10.1007\/s12350-017-1059-9","journal-title":"J Nucl Cardiol"},{"issue":"7","key":"6727_CR13","doi-asserted-by":"publisher","first-page":"e000029","DOI":"10.1161\/HCI.0000000000000029","volume":"14","author":"S Dorbala","year":"2021","unstructured":"Dorbala S, Ando Y, Bokhari S, et al. ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging. Circ Cardiovasc Imaging. 2021;14(7):e000029. https:\/\/doi.org\/10.1161\/HCI.0000000000000029","journal-title":"Circ Cardiovasc Imaging"},{"issue":"7","key":"6727_CR14","doi-asserted-by":"publisher","first-page":"e000030","DOI":"10.1161\/HCI.0000000000000030","volume":"14","author":"S Dorbala","year":"2021","unstructured":"Dorbala S, Ando Y, Bokhari S, et al. ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 2 of 2-diagnostic criteria and appropriate utilization. Circ Cardiovasc Imaging. 2021;14(7):e000030. https:\/\/doi.org\/10.1161\/HCI.0000000000000030","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"6727_CR15","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s12350-020-02152-x","volume":"28","author":"C Cuscaden","year":"2021","unstructured":"Cuscaden C, Ramsay SC, Prasad S, Goodwin B, Smith J. Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation. J Nucl Cardiol. 2021;28(6):2845\u201356. https:\/\/doi.org\/10.1007\/s12350-020-02152-x","journal-title":"J Nucl Cardiol"},{"key":"6727_CR16","doi-asserted-by":"publisher","unstructured":"Saric P, Young KA, Rodriguez-Porcel M, Chareonthaitawee P. PET imaging in cardiac sarcoidosis: a narrative review with focus on novel PET tracers. Pharmaceuticals (Basel). 2021;14(12). https:\/\/doi.org\/10.3390\/ph14121286","DOI":"10.3390\/ph14121286"},{"issue":"1100","key":"6727_CR17","doi-asserted-by":"publisher","first-page":"20190247","DOI":"10.1259\/bjr.20190247","volume":"92","author":"D Genovesi","year":"2019","unstructured":"Genovesi D, Bauckneht M, Altini C, et al. The role of positron emission tomography in the assessment of cardiac sarcoidosis. Br J Radiol. 2019;92(1100):20190247. https:\/\/doi.org\/10.1259\/bjr.20190247","journal-title":"Br J Radiol"},{"issue":"2 Pt 2","key":"6727_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","volume":"11","author":"BW Sperry","year":"2018","unstructured":"Sperry BW, Tamarappoo BK, Oldan JD, et al. Prognostic impact of extent, severity, and heterogeneity of abnormalities on 18F-FDG PET scans for suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2018;11(2 Pt 2):336\u201345. https:\/\/doi.org\/10.1016\/j.jcmg.2017.04.020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"6727_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","volume":"63","author":"R Blankstein","year":"2014","unstructured":"Blankstein R, Osborne M, Naya M, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014;63(4):329\u201336. https:\/\/doi.org\/10.1016\/j.jacc.2013.09.022","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"6727_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/ehjci\/jex146","volume":"18","author":"EACVI Reviewers","year":"2017","unstructured":"Writing group, Document reading group, Reviewers EACVI. This document was reviewed by members of the EACVI Scientific Documents Committee for 2014\u20132016 and 2016\u20132018. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. Eur Heart J Cardiovasc Imaging. 2017;18(10):1073\u201389. https:\/\/doi.org\/10.1093\/ehjci\/jex146","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"6727_CR21","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","volume":"58","author":"P Chareonthaitawee","year":"2017","unstructured":"Chareonthaitawee P, Beanlands RS, Chen W, et al. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med. 2017;58(8):1341\u201353. https:\/\/doi.org\/10.2967\/jnumed.117.196287","journal-title":"J Nucl Med"},{"issue":"37","key":"6727_CR22","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503\u2013626. https:\/\/doi.org\/10.1093\/eurheartj\/ehad194","journal-title":"Eur Heart J"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06727-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-024-06727-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06727-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T10:08:04Z","timestamp":1717063684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-024-06727-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["6727"],"URL":"https:\/\/doi.org\/10.1007\/s00259-024-06727-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]},"assertion":[{"value":"29 April 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were by the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent to anonymously collect and publish personal and opinion data of this survey was obtained on the presentation page of the web questionnaire.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}